253 related articles for article (PubMed ID: 23924694)
1. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
2. A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes.
Ito M; Nagasawa M; Omae N; Tsunoda M; Ishiyama J; Ide T; Akasaka Y; Murakami K
J Lipid Res; 2013 Jun; 54(6):1531-1540. PubMed ID: 23515281
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
4. Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes.
Guntur KV; Guilherme A; Xue L; Chawla A; Czech MP
J Biol Chem; 2010 Feb; 285(9):6595-603. PubMed ID: 20038583
[TBL] [Abstract][Full Text] [Related]
5. SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes.
Du J; Chen Q; Takemori H; Xu H
Obesity (Silver Spring); 2008 Mar; 16(3):531-8. PubMed ID: 18239551
[TBL] [Abstract][Full Text] [Related]
6. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport.
Tang X; Guilherme A; Chakladar A; Powelka AM; Konda S; Virbasius JV; Nicoloro SM; Straubhaar J; Czech MP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2087-92. PubMed ID: 16461467
[TBL] [Abstract][Full Text] [Related]
7. Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes.
Nadeau KJ; Leitner JW; Gurerich I; Draznin B
J Biol Chem; 2004 Aug; 279(33):34380-7. PubMed ID: 15187085
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.
Tesz GJ; Guilherme A; Guntur KV; Hubbard AC; Tang X; Chawla A; Czech MP
J Biol Chem; 2007 Jul; 282(27):19302-12. PubMed ID: 17500068
[TBL] [Abstract][Full Text] [Related]
9. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
10. Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes.
Rao Y; Liu H; Gao L; Yu H; Tan JH; Ou TM; Huang SL; Gu LQ; Ye JM; Huang ZS
Bioorg Med Chem; 2015 Aug; 23(15):4719-4727. PubMed ID: 26088335
[TBL] [Abstract][Full Text] [Related]
11. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
13. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
[TBL] [Abstract][Full Text] [Related]
14. Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes.
Jang J; Jung Y; Seo SJ; Kim SM; Shim YJ; Cho SH; Chung SI; Yoon Y
Mol Med Rep; 2017 Jun; 15(6):4139-4147. PubMed ID: 28487951
[TBL] [Abstract][Full Text] [Related]
15. Arctigenin improves lipid metabolism by regulating AMP-activated protein kinase and downstream signaling pathways.
Song Y; Li X; Liu Y; Hu Y; Yang R
J Cell Biochem; 2019 Aug; 120(8):13275-13288. PubMed ID: 30891825
[TBL] [Abstract][Full Text] [Related]
16. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK.
Chen S; Li Z; Li W; Shan Z; Zhu W
Can J Physiol Pharmacol; 2011 Nov; 89(11):793-9. PubMed ID: 22017765
[TBL] [Abstract][Full Text] [Related]
18. Connecting mTORC1 signaling to SREBP-1 activation.
Bakan I; Laplante M
Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814
[TBL] [Abstract][Full Text] [Related]
19. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
20. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
